GSA Capital Partners’s Ventyx Biosciences VTYX Stock Holding History

GSA Capital Partners’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-172,363	Closed	-$1.56M	–	2201
2025 Q4	$1.56M	Sell	172,363 -69,866	-29%	-$522K	0.13%	166
2025 Q3	$753K	Buy	+242,229	New	+$642K	0.06%	581
2024 Q1	–	Sell	-221,185	Closed	-$546K	–	2006
2023 Q4	$546K	Buy	+221,185	New	+$2.1M	0.05%	739

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GSA Capital Partners's VTYX Position: Q1 2026 in Review

GSA Capital Partners sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 172,363 shares — an estimated $1.56M sold.

GSA Capital Partners first reported a position in VTYX in Q4 2023 and held it in 3 quarters. The position peaked at $1.56M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

GSA Capital Partners reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
GSA Capital Partners sold 172,363 Ventyx Biosciences shares in Q1 2026, an estimated $1.56M.
GSA Capital Partners first reported a position in Ventyx Biosciences in Q4 2023 and held it in 3 quarters.
GSA Capital Partners's Ventyx Biosciences position peaked at $1.56M in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.